NPI: 1376781989 · CASSELBERRY, FL 32707 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/04/2009
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/04/2009 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 12,864 | $1.73M |
| 2019 | 23,051 | $2.67M |
| 2020 | 15,370 | $2.30M |
| 2021 | 5,757 | $671K |
| 2022 | 1,620 | $320K |
| 2023 | 714 | $76K |
| 2024 | 769 | $38K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 19,239 | 1,227 | $2.43M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 18,109 | 622 | $2.23M |
| J1270 | Injection, doxercalciferol, 1 mcg | 11,924 | 725 | $1.59M |
| A4657 | Syringe, with or without needle, each | 2,394 | 906 | $555K |
| J1756 | Injection, iron sucrose, 1 mg | 3,404 | 452 | $369K |
| 85048 | 1,116 | 621 | $137K | |
| 85041 | 1,116 | 621 | $137K | |
| 83970 | 719 | 413 | $83K | |
| 83550 | 521 | 302 | $62K | |
| 83540 | 526 | 302 | $62K | |
| 82728 | 519 | 296 | $61K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 174 | 108 | $28K |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 112 | 66 | $17K |
| 82607 | 78 | 48 | $13K | |
| 82746 | 76 | 47 | $13K | |
| 82108 | 84 | 50 | $13K | |
| G0008 | Administration of influenza virus vaccine | 34 | 14 | $4K |